Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia.

Huppke P, Wegener E, Gilley J, Angeletti C, Kurth I, Drenth JPH, Stadelmann C, Barrantes-Freer A, Brück W, Thiele H, Nürnberg P, Gärtner J, Orsomando G, Coleman MP.

Exp Neurol. 2019 Oct;320:112958. doi: 10.1016/j.expneurol.2019.112958. Epub 2019 May 24.

PMID:
31132363
2.

Polymer Brushes on Hexagonal Boron Nitride.

Sheng W, Amin I, Neumann C, Dong R, Zhang T, Wegener E, Chen WL, Förster P, Tran HQ, Löffler M, Winter A, Rodriguez RD, Zschech E, Ober CK, Feng X, Turchanin A, Jordan R.

Small. 2019 May;15(19):e1805228. doi: 10.1002/smll.201805228. Epub 2019 Apr 1.

PMID:
30932320
3.

Electrophilic Organoiridium(III) Pincer Complexes on Sulfated Zirconia for Hydrocarbon Activation and Functionalization.

Syed ZH, Kaphan DM, Perras FA, Pruski M, Ferrandon MS, Wegener EC, Celik G, Wen J, Liu C, Dogan F, Goldberg KI, Delferro M.

J Am Chem Soc. 2019 Apr 17;141(15):6325-6337. doi: 10.1021/jacs.9b00896. Epub 2019 Apr 5.

PMID:
30900885
4.

Family history of venous thromboembolism in the paediatric population: The need for a standardized definition.

Hau A, Wegener E, Ignjatovic V, Revel-Vilk S, Monagle P.

Thromb Res. 2019 Jan;173:91-95. doi: 10.1016/j.thromres.2018.11.016. Epub 2018 Nov 16. Review.

PMID:
30500675
5.

Dominant Role of Entropy in Stabilizing Sugar Isomerization Transition States within Hydrophobic Zeolite Pores.

Cordon MJ, Harris JW, Vega-Vila JC, Bates JS, Kaur S, Gupta M, Witzke ME, Wegener EC, Miller JT, Flaherty DW, Hibbitts DD, Gounder R.

J Am Chem Soc. 2018 Oct 31;140(43):14244-14266. doi: 10.1021/jacs.8b08336. Epub 2018 Oct 19.

PMID:
30265002
6.

Identification of active sites on supported metal catalysts with carbon nanotube hydrogen highways.

Briggs NM, Barrett L, Wegener EC, Herrera LV, Gomez LA, Miller JT, Crossley SP.

Nat Commun. 2018 Sep 20;9(1):3827. doi: 10.1038/s41467-018-06100-9.

7.

One step 3D printing of surface functionalized composite scaffolds for tissue engineering applications.

Kotlarz M, Jordan R, Wegener E, Dobrzyński P, Neunzehn J, Lederer A, Wolf-Brandstetter C, Pamuła E, Scharnweber D.

Acta Bioeng Biomech. 2018;20(2):35-45.

PMID:
30220727
8.

Poly(2-oxazoline)s based biomaterials: A comprehensive and critical update.

Lorson T, Lübtow MM, Wegener E, Haider MS, Borova S, Nahm D, Jordan R, Sokolski-Papkov M, Kabanov AV, Luxenhofer R.

Biomaterials. 2018 Sep;178:204-280. doi: 10.1016/j.biomaterials.2018.05.022. Epub 2018 Jun 2. Review.

PMID:
29945064
9.

Publisher Correction: A molecular cross-linking approach for hybrid metal oxides.

Jung D, Saleh LMA, Berkson ZJ, El-Kady MF, Hwang JY, Mohamed N, Wixtrom AI, Titarenko E, Shao Y, McCarthy K, Guo J, Martini IB, Kraemer S, Wegener EC, Saint-Cricq P, Ruehle B, Langeslay RR, Delferro M, Brosmer JL, Hendon CH, Gallagher-Jones M, Rodriguez J, Chapman KW, Miller JT, Duan X, Kaner RB, Zink JI, Chmelka BF, Spokoyny AM.

Nat Mater. 2018 Apr;17(4):369. doi: 10.1038/s41563-018-0054-0.

PMID:
29549301
10.

A molecular cross-linking approach for hybrid metal oxides.

Jung D, Saleh LMA, Berkson ZJ, El-Kady MF, Hwang JY, Mohamed N, Wixtrom AI, Titarenko E, Shao Y, McCarthy K, Guo J, Martini IB, Kraemer S, Wegener EC, Saint-Cricq P, Ruehle B, Langeslay RR, Delferro M, Brosmer JL, Hendon CH, Gallagher-Jones M, Rodriguez J, Chapman KW, Miller JT, Duan X, Kaner RB, Zink JI, Chmelka BF, Spokoyny AM.

Nat Mater. 2018 Apr;17(4):341-348. doi: 10.1038/s41563-018-0021-9. Epub 2018 Mar 5. Erratum in: Nat Mater. 2018 Mar 16;:.

PMID:
29507417
11.

High-Performance Transition Metal Phosphide Alloy Catalyst for Oxygen Evolution Reaction.

Liu K, Zhang C, Sun Y, Zhang G, Shen X, Zou F, Zhang H, Wu Z, Wegener EC, Taubert CJ, Miller JT, Peng Z, Zhu Y.

ACS Nano. 2018 Jan 23;12(1):158-167. doi: 10.1021/acsnano.7b04646. Epub 2017 Dec 11.

PMID:
29211437
12.

Speciation of CuCl and CuCl2 Thiol-Amine Solutions and Characterization of Resulting Films: Implications for Semiconductor Device Fabrication.

Murria P, Miskin CK, Boyne R, Cain LT, Yerabolu R, Zhang R, Wegener EC, Miller JT, Kenttämaa HI, Agrawal R.

Inorg Chem. 2017 Dec 4;56(23):14396-14407. doi: 10.1021/acs.inorgchem.7b01359. Epub 2017 Nov 13.

PMID:
29131598
13.

Dehydrogenative Transformations of Imines Using a Heterogeneous Photocatalyst.

Adolph CM, Werth J, Selvaraj R, Wegener EC, Uyeda C.

J Org Chem. 2017 Jun 2;82(11):5959-5965. doi: 10.1021/acs.joc.7b00617. Epub 2017 May 15.

PMID:
28485932
14.

Compound heterozygous variants in PGAP1 causing severe psychomotor retardation, brain atrophy, recurrent apneas and delayed myelination: a case report and literature review.

Kettwig M, Elpeleg O, Wegener E, Dreha-Kulaczewski S, Henneke M, Gärtner J, Huppke P.

BMC Neurol. 2016 May 21;16:74. doi: 10.1186/s12883-016-0602-7. Review.

15.

Patterned Polypeptoid Brushes.

Schneider M, Tang Z, Richter M, Marschelke C, Förster P, Wegener E, Amin I, Zimmermann H, Scharnweber D, Braun HG, Luxenhofer R, Jordan R.

Macromol Biosci. 2016 Jan;16(1):75-81. doi: 10.1002/mabi.201500314. Epub 2015 Nov 2.

PMID:
26524353
16.

Characterization of the MeCP2R168X knockin mouse model for Rett syndrome.

Wegener E, Brendel C, Fischer A, Hülsmann S, Gärtner J, Huppke P.

PLoS One. 2014 Dec 26;9(12):e115444. doi: 10.1371/journal.pone.0115444. eCollection 2014.

17.

Tectonic gene mutations in patients with Joubert syndrome.

Huppke P, Wegener E, Böhrer-Rabel H, Bolz HJ, Zoll B, Gärtner J, Bergmann C.

Eur J Hum Genet. 2015 May;23(5):616-20. doi: 10.1038/ejhg.2014.160. Epub 2014 Aug 13. Review.

18.

Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s.

Schulz A, Jaksch S, Schubel R, Wegener E, Di Z, Han Y, Meister A, Kressler J, Kabanov AV, Luxenhofer R, Papadakis CM, Jordan R.

ACS Nano. 2014 Mar 25;8(3):2686-96. doi: 10.1021/nn406388t. Epub 2014 Feb 27.

19.

MIA is a potential biomarker for tumour load in neurofibromatosis type 1.

Kolanczyk M, Mautner V, Kossler N, Nguyen R, Kühnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B, Tinschert S, Holtkamp N, Park SJ, Birch P, Kendler D, Harder A, Mundlos S, Kluwe L.

BMC Med. 2011 Jul 4;9:82. doi: 10.1186/1741-7015-9-82.

20.

Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.

Brendel C, Belakhov V, Werner H, Wegener E, Gärtner J, Nudelman I, Baasov T, Huppke P.

J Mol Med (Berl). 2011 Apr;89(4):389-98. doi: 10.1007/s00109-010-0704-4. Epub 2010 Dec 1. Erratum in: J Mol Med (Berl). 2013 Jun;91(6):775.

21.

Identification of common nail and skin disorders.

Wegener EE, Johnson WR.

J Hand Ther. 2010 Apr-Jun;23(2):187-97; quiz 198. doi: 10.1016/j.jht.2009.12.002. Epub 2010 Mar 20. Review.

PMID:
20304604
22.

Dynamic protein complexes regulate NF-kappaB signaling.

Wegener E, Krappmann D.

Handb Exp Pharmacol. 2008;(186):237-59. doi: 10.1007/978-3-540-72843-6_10. Review.

PMID:
18491055
23.

Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.

Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D.

EMBO J. 2007 Nov 14;26(22):4634-45. Epub 2007 Oct 18.

24.

MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.

Ferch U, zum Büschenfelde CM, Gewies A, Wegener E, Rauser S, Peschel C, Krappmann D, Ruland J.

Nat Immunol. 2007 Sep;8(9):984-91. Epub 2007 Jul 29.

PMID:
17660823
25.

CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.

Wegener E, Krappmann D.

Sci STKE. 2007 May 1;2007(384):pe21.

PMID:
17473310
26.

Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.

Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, Tatzelt J, Winklhofer KF.

J Neurosci. 2007 Feb 21;27(8):1868-78.

27.

Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.

Wegener E, Oeckinghaus A, Papadopoulou N, Lavitas L, Schmidt-Supprian M, Ferch U, Mak TW, Ruland J, Heissmeyer V, Krappmann D.

Mol Cell. 2006 Jul 7;23(1):13-23.

28.

The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.

Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, Mordmuller B, Scheidereit C.

Mol Cell Biol. 2004 Jul;24(14):6488-500.

29.

Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D.

Mol Cell Biol. 2004 May;24(9):3860-73.

30.

Principles of internal fixation as applied to the hand and wrist.

Jabaley ME, Wegener EE.

J Hand Ther. 2003 Apr-Jun;16(2):95-104. Review. No abstract available.

PMID:
12755161
31.

Hand fracture management.

Hardy M, Wegener E.

J Hand Ther. 2003 Apr-Jun;16(2):79-80. No abstract available.

PMID:
12755159
32.

Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.

Mordmüller B, Krappmann D, Esen M, Wegener E, Scheidereit C.

EMBO Rep. 2003 Jan;4(1):82-7.

33.

The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha5 and alpha6 subunits.

El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, Laplantine E, Geerts D, Georges-Labouesse E, Sonnenberg A, Aumailley M.

Matrix Biol. 2002 Mar;21(2):207-14.

PMID:
11852236
34.

Glomus tumors of the nail unit: a plastic surgeon's approach.

Wegener EE.

Dermatol Surg. 2001 Mar;27(3):240-1. No abstract available.

PMID:
11277889
35.

Use of a closing wedge osteotomy to correct malunion of dorsally displaced extra-articular distal radius fractures.

Viso R, Wegener EE, Freeland AE.

Orthopedics. 2000 Jul;23(7):721-4. No abstract available.

PMID:
10917249
36.

Mutilating injuries to the hand: early amputation or repair and reconstruction.

Arellano AO, Wegener EE, Freeland AE.

Orthopedics. 1999 Jul;22(7):683-4. Review. No abstract available.

PMID:
10418865
37.

Severe frostbite caused by Freon gas.

Wegener EE, Barraza KR, Das SK.

South Med J. 1991 Sep;84(9):1143-6.

PMID:
1891741
38.

[Efficient measurement of cell nuclear volume].

Hildebrand R, Wegener E.

Gegenbaurs Morphol Jahrb. 1980;126(6):965-8. German.

PMID:
7011894
39.

Use of mass media in dental health education and prevention programs.

Wegener EP.

J Ala Dent Assoc. 1975 Jan;59(1):47-50. No abstract available.

PMID:
1056953
40.

[Surgical cosmetic indications in youth and old age].

Wegener EH.

Asthet Med (Berl). 1968 Nov;17(11):255-6. German. No abstract available.

PMID:
5305092
41.

[Prof. Hellmut Haubold, MD, October 2, 1905-September 19, 1968].

Wegener EH.

Asthet Med (Berl). 1968 Nov;17(11):267-8. German. No abstract available.

PMID:
4888198
42.

[What must the general practitioner and the specialist know about diagnosis and the possibilities of modern treatment of facial paralysis? (XI. Congress of Münster 19 till 21 May 1966)].

Nessel E, Zühlke, Oppliger GC, Meyer R, Wegener EH, Denecke HJ, Wilflingseder P, Miehlke A.

Asthet Med (Berl). 1967 Jun 20;16(6):193-5. German. No abstract available.

PMID:
5303549
43.

[Therapeutic possibilities of facial paralysis in view of the esthetic results].

Wegener EH.

Asthet Med (Berl). 1967 Jun 20;16(6):183-6. German. No abstract available.

PMID:
5303242
44.

[Experience with a special method in the treatment of wounds after operations on disfiguring tumors and lesions of the skin].

WEGENER EH.

Minerva Chir. 1961 Dec 15;16:1511-3. Italian. No abstract available.

PMID:
14005557
45.

[Contribution on the avoidance of postoperative complications in plastic surgery].

WEGENER EH.

Zentralbl Chir. 1960 Oct 1;85:1975-83. German. No abstract available.

PMID:
13783729
46.

[Studies on keloid therapy].

WEGENER EH.

Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1958;289:725-9. German. No abstract available.

PMID:
13599605
47.

[A new re-implantation method for correction of a saddle-nose].

WEGENER EH.

Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1957;287:770-3. German. No abstract available.

PMID:
13526473
48.

[Plasticcosmetic surgery of the face and breast].

WEGENER EH.

Minerva Chir. 1956 Dec 31;11(24):1317-20. Italian. No abstract available.

PMID:
13399864
49.

[The treatment of the varicose syndrome, with reference to cosmetic surgery].

WEGENER EH.

Medizinische. 1953 Nov 28;48:1551-3. Undetermined Language. No abstract available.

PMID:
13132353
50.

[Extension potentials of the sartorius muscle and the myocardium of the frog].

ROTHSCHUH KE, WEGENER E, MEIER A.

Pflugers Arch Gesamte Physiol Menschen Tiere. 1951 Dec;254(2):171-92. Undetermined Language. No abstract available.

PMID:
14948410

Supplemental Content

Loading ...
Support Center